BioCatalyst

Sacituzumab tirumotecan, Trifluridine-Tipiracil, Irinotecan, Paclitaxel — catalyst calendar

1 verified catalyst event(s) referencing Sacituzumab tirumotecan, Trifluridine-Tipiracil, Irinotecan, Paclitaxel, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-04
in 4mo
ESTIMATED
 READOUT
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gas
Phase 3 · Gastroesophageal Cancer
 Merck Sharp & Dohme LLC Sacituzumab tirumotecan, Trifluridine-Ti ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.